相关实验视频

Updated: May 15, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

与患者大小相比,对神经皮瘤的预后分析 - 患者大小

Jueun Park¹, Suhyeon Ha¹, Hyunhee Kwon¹

¹Division of Pediatric Surgery, Asan Medical Center Children's Hospital, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Frontiers in pediatrics

|April 8, 2025

概括

新的指标,瘤体积/出生体重比率 (VWR) 和瘤长度/出生高度比率 (LHR),有助于预测手术结果和乳腺瘤 (SCT) 婴儿的预后. 这些指标为评估大型瘤风险提供了客观的指标.

科学领域:

儿科手术儿科手术
新生儿护理新生儿护理
在瘤学瘤学.

背景情况:

乳腺瘤 (Sacrococcygeal teratoma,简称SCT) 面临着外科手术的挑战,尤其是巨型瘤,影响婴儿发病率和死亡率.
缺乏客观的标准来定义与婴儿大小相对较大的SCT,这阻碍了准确的预后.
了解产后结果对于推进SCT产前护理策略至关重要.

研究的目的:

建立客观的瘤大小指标,用于预测手术结果和神经囊瘤患者的预后.
定义可靠的指标来评估与大型SCT相关的风险.

主要方法:

在2000年至2021年间,对97名SCT手术治疗的患者进行了回顾性评估.
测量瘤体积/出生体重比 (VWR) 和瘤长度/出生高度比 (LHR).
基于VWR和LHR的手术结果的评估,包括并发症,重复手术和复发.

主要成果:

38名患者出现了短期并发症,18人需要额外的手术,16人出现了长期并发症,14人出现了复发.
无论是VWR还是LHR,都显示出与短期和长期并发症,需要额外的手术和瘤复发的显著相关性.
VWR和LHR显示了手术结果和预后的可比预测能力.

结论:

目标瘤大小指标VWR和LHR与SCT的预后和手术结果有显著的关联.
虽然精确的截止值需要在更大的队列中进一步验证,但这些指标在风险分层方面表现有前途.
VWR和LHR提供了有价值的,可比的指标,用于评估神经皮瘤的严重程度和预测病程.

关键词:

儿科瘤学儿科瘤学儿科外科手术儿科外科手术预后预后预后这是一种神圣的瘤 (sacrococcygeal teratoma).手术并发症是手术并发症.

更多相关视频

Teratoma Generation in the Testis Capsule

Teratoma Generation in the Testis Capsule

Published on: November 7, 2011

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

Published on: October 11, 2022

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...